Canada identifies 629 substances that warrant further review

摘要

Canada has identified 629 substances as candidates for further consideration as a part of its Identification of Risk Assessment Priorities (IRAP) process. IRAP is a cyclical review process in which the Canadian government identifies and prioritises substances that may require additional consideration. The government announced the results of the 2019 IRAP on 30 November.